SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-012254
Filing Date
2020-05-14
Accepted
2020-05-14 16:06:03
Documents
48
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0320_aikidopharma.htm 10-Q 513120
2 CERTIFICATION f10q0320ex31-1_aikidopharma.htm EX-31.1 15478
3 CERTIFICATION f10q0320ex32-1_aikidopharma.htm EX-32.1 6787
  Complete submission text file 0001213900-20-012254.txt   2127042

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE alki-20200331.xml EX-101.INS 222783
5 XBRL SCHEMA FILE alki-20200331.xsd EX-101.SCH 40855
6 XBRL CALCULATION FILE alki-20200331_cal.xml EX-101.CAL 35236
7 XBRL DEFINITION FILE alki-20200331_def.xml EX-101.DEF 106138
8 XBRL LABEL FILE alki-20200331_lab.xml EX-101.LAB 245739
9 XBRL PRESENTATION FILE alki-20200331_pre.xml EX-101.PRE 172184
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
Aikido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-05576 | Film No.: 20877739
SIC: 8731 Services-Commercial Physical & Biological Research